BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 28340496)

  • 1. Recent developments in nanomedicine for melanoma treatment.
    Tang JQ; Hou XY; Yang CS; Li YX; Xin Y; Guo WW; Wei ZP; Liu YQ; Jiang G
    Int J Cancer; 2017 Aug; 141(4):646-653. PubMed ID: 28340496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanoparticle-mediated drug delivery for treating melanoma.
    Mundra V; Li W; Mahato RI
    Nanomedicine (Lond); 2015; 10(16):2613-33. PubMed ID: 26244818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent Advances in Polymeric Nanosystems for Treating Cutaneous Melanoma and Its Metastasis.
    Chou YP; Lin YK; Chen CH; Fang JY
    Curr Pharm Des; 2017; 23(35):5301-5314. PubMed ID: 28699537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticancer Drug Delivery: An Update on Clinically Applied Nanotherapeutics.
    Marchal S; El Hor A; Millard M; Gillon V; Bezdetnaya L
    Drugs; 2015 Sep; 75(14):1601-11. PubMed ID: 26323338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanomedicine as a potent strategy in melanoma tumor microenvironment.
    Pautu V; Leonetti D; Lepeltier E; Clere N; Passirani C
    Pharmacol Res; 2017 Dec; 126():31-53. PubMed ID: 28223185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent progress in nanomedicine for enhanced cancer chemotherapy.
    Wei G; Wang Y; Yang G; Wang Y; Ju R
    Theranostics; 2021; 11(13):6370-6392. PubMed ID: 33995663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanocarrier-Based Drug Delivery for Melanoma Therapeutics.
    Song M; Liu C; Chen S; Zhang W
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33668591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current Progresses of Functional Nanomaterials for Imaging Diagnosis and Treatment of Melanoma.
    Zhu C; Zhu Y; Pan H; Chen Z; Zhu Q
    Curr Top Med Chem; 2019; 19(27):2494-2506. PubMed ID: 31642783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New strategies in melanoma therapy: can nanoparticles overcome chemoresistance?
    Badea I
    Nanomedicine (Lond); 2017 Jul; 12(14):1623-1626. PubMed ID: 28635551
    [No Abstract]   [Full Text] [Related]  

  • 11. Injectable Drug-Loaded Nanocarriers for Lung Cancer Treatments.
    Yu HP; Aljuffali IA; Fang JY
    Curr Pharm Des; 2017; 23(3):481-494. PubMed ID: 28292243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Photodynamic Therapy for Metastatic Melanoma Treatment: A Review.
    Naidoo C; Kruger CA; Abrahamse H
    Technol Cancer Res Treat; 2018 Jan; 17():1533033818791795. PubMed ID: 30099929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted drug delivery to melanoma.
    Liu Q; Das M; Liu Y; Huang L
    Adv Drug Deliv Rev; 2018 Mar; 127():208-221. PubMed ID: 28939379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent advances in targeted nanoparticles drug delivery to melanoma.
    Li J; Wang Y; Liang R; An X; Wang K; Shen G; Tu Y; Zhu J; Tao J
    Nanomedicine; 2015 Apr; 11(3):769-94. PubMed ID: 25555352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanocarriers for microRNA delivery in cancer medicine.
    Fernandez-Piñeiro I; Badiola I; Sanchez A
    Biotechnol Adv; 2017; 35(3):350-360. PubMed ID: 28286148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanooncology: the future of cancer diagnosis and therapy.
    Thakor AS; Gambhir SS
    CA Cancer J Clin; 2013; 63(6):395-418. PubMed ID: 24114523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Photodynamic therapy in treatment of cutaneous and choroidal melanoma.
    Kawczyk-Krupka A; Bugaj AM; Latos W; Zaremba K; Sieroń A
    Photodiagnosis Photodyn Ther; 2013 Dec; 10(4):503-9. PubMed ID: 24284103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanotechnology-based strategies for combating toxicity and resistance in melanoma therapy.
    Brys AK; Gowda R; Loriaux DB; Robertson GP; Mosca PJ
    Biotechnol Adv; 2016; 34(5):565-577. PubMed ID: 26826558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New therapeutic options in the medical management of advanced melanoma.
    Lutzky J
    Semin Cutan Med Surg; 2010 Dec; 29(4):249-57. PubMed ID: 21277538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel strategies in melanoma treatment using silver nanoparticles.
    Zhao J; Gao N; Xu J; Zhu X; Ling G; Zhang P
    Cancer Lett; 2023 May; 561():216148. PubMed ID: 36990267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.